State mandatory paid medical leave policies and survival among adults with cancer in the US.

Authors

Justin Barnes

Justin Michael Barnes

Department of Radiation Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO

Justin Michael Barnes , Fumiko Chino , Kimberly J. Johnson , Zhiyuan Zheng , Xuesong Han , Robin Yabroff , Kenton J Johnston

Organizations

Department of Radiation Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO, Memorial Sloan Kettering Cancer Center, New York, NY, Washington University, St. Louis, MO, American Cancer Society, Atlanta, GA, Washington University in St. Louis, St. Louis, MO

Research Funding

No funding received
None.

Background: Cancer treatment is often costly and time intensive. Paid medical leave can help employed patients with cancer more effectively manage side effects and complete recommended cancer treatments without loss of income. Since 2012, several states have introduced mandatory paid medical leave policies. We examined whether mandatory paid medical leave policies were associated with better survival among working age adults with cancer. Methods: Adults ages 18 to 64 years diagnosed with cancer 2007- 2019 were identified from the Surveillance, Epidemiology, and End Results registry program covering 12 states. The primary outcome was overall survival (OS). The exposure of interest was the presence of state mandatory paid medical leave policies. Difference-in-differences (DID) analyses with additive hazards regression models compared changes in OS from pre- to post- mandatory paid sick leave policy implementation in states with vs. without paid sick leave policies. Models adjusted for year-quarter fixed effects, state fixed effects, state Medicaid expansion status, age, race, sex, marital status, metropolitan residence status, county-level income, cancer site, cancer stage, and insurance status. Clustered standard errors by state were achieved via the cluster bootstrap. The plausibility of the common trends assumption was tested using event study analyses and was satisfied for all analyses. Primary analyses focused on data from 2007-2016, where information on month of diagnosis, county, and insurance coverage status were available (note these variables are not available for 2017-2019), though sensitivity analyses with data through 2019 without these additional variables were conducted. Results: A total of 1,491,208 adults with cancer were identified. In adjusted DID analyses, after policy implementation, 1-year OS improved from 85.0% to 86.4% in states with mandatory medical leave policies compared to 85.1% to 85.6% in states without such policies. This translates to a 0.85% improvement in 1-year OS (hazard DID: -0.0007, 95% CI = -0.0016 to -0.0001, P = .027). The largest improvement was found among the uninsured population (hazard DID: -0.0038, 95% CI = -0.0076 to -0.0011, P = .013). In sensitivity analyses with abbreviated data through 2019, results were similar (DID for 1-year OS: 1.3%; hazard DID: -0.0010, 95% CI = -0.0025, 0.0001, P = .070). Conclusions: State mandatory paid medical leave was associated with improved survival for working-age adults with newly diagnosed cancer, particularly for those who are uninsured. Policy changes that better support patients through cancer treatment may pay off with improved cancer outcomes.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Care Delivery and Regulatory Policy

Track

Care Delivery and Quality Care

Sub Track

Health and Regulatory Policy

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 1511)

DOI

10.1200/JCO.2023.41.16_suppl.1511

Abstract #

1511

Poster Bd #

105

Abstract Disclosures

Similar Abstracts

First Author: Hanna Kakish

Abstract

2023 ASCO Gastrointestinal Cancers Symposium

The impact of race and ethnicity on survival in primary liver cancer: A propensity-adjusted analysis.

First Author: Muhammet Ozer

First Author: Chakra Pani Chaulagain